Neoantigen vaccine: an emerging tumor immunotherapy
2019 · Molecular Cancer · 688 citations
https://doi.org/10.1186/s12943-019-1055-6
Y
Yian Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
300
Papers
8.6K
Citations
47
h-index
127
i10-index
Yian Wang is an academic researcher from Houston Methodist. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related Molecular Pathways & Lung Cancer Treatments and Mutations. The author has an h-index of 47, co-authored 255 publications.
Papers by this author
worksA gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
2020 · Nature Communications · 239 citations
https://doi.org/10.1038/s41467-020-18546-x
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
2012 · Carcinogenesis · 205 citations
https://doi.org/10.1093/carcin/bgs148
Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop
2022 · Molecular Cancer · 113 citations
https://doi.org/10.1186/s12943-022-01502-2
Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents
2020 · Cancer Prevention Research · 85 citations
https://doi.org/10.1158/1940-6207.capr-20-0425
Efficacy of Polyphenon E, Red Ginseng, and Rapamycin on Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice
2006 · Neoplasia · 65 citations
https://doi.org/10.1593/neo.05652
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat